Goal Attainment Scaling in Upper Limb Spasticity Treatment

Recruiting now · Not applicable

Conditions studied: Ischemic Stroke, Hemorrhagic Stroke

In brief

Patients after stroke with upper limb spasticity treated with botulinum toxin-A (BTX-A) will be included in this two-part study. In the first part, goal attainment scaling and comprehensive assessment of motor functioning will be performed before BTX-A application and after two weeks. In the second part, the patients will be randomised into a test group performing prescribed regular exercise for two weeks and a control group exercising at their own discretion during the same period, whereby the patients' health-related quality of life will be assessed at the beginning and end of the two-week period.

Key facts

Study ID

NCT04975646

Run by

University Rehabilitation Institute, Republic of Slovenia

People needed

70

Starts

2021-01-03

Expected to finish

2026-10-01

Last updated by the study team

2026-06-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• patient's or caregiver's approval
• ischemic or hemorrhagic stroke diagnosed using head CT/MRI
• at least one upper limb muscle spasticity (MAS ≥ 3)
• candidate for BTX-A treatment or already given BTX-A in the past
• patient's or caregiver's capability for goal attainment protocol cooperation (Mini Mental Examination ≥ 24 points)

You may not qualify if…

• aphasic patients without caregiver's presence
• other neurological or musculoskeletal diseases that could affect the treatment outcome

Where it is running

• University Rehabilitation Institute, Republic of Slovenia — Ljubljana, Slovenia (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.